Skip to content
PeptideGeek

Immune system

Lactoferricin B, explained simply

A germ-fighting peptide released when a milk protein is digested — studied against bacteria, biofilms, and possibly tumors.

Some human studiesTaken by mouth5 cited sourcesResearch compound — not FDA approved

Start here

What is Lactoferricin B?

Lactoferricin B is a germ-fighting peptide released when stomach enzymes digest lactoferrin, an iron-binding protein found in cow's milk — your own digestion produces it naturally as part of the gut's defenses. In research it kills a broad range of bacteria and fungi, breaks up bacterial biofilms, and shows early anticancer activity. It is a research compound, not an approved drug.

How it works in your body

Lactoferricin is an antimicrobial peptide derived from milk proteins that fights bacteria, fungi, and viruses while supporting immune function and reducing inflammation—making it a natural immune booster from breast milk.

The deeper mechanism, for the curious

Lactoferricin is a germ-killing peptide made of 25 amino acids. It forms when pepsin (a stomach enzyme) or other protein-cutting enzymes snip it from lactoferrin (an iron-binding protein found in milk). It carries a positive charge, which pulls it onto bacterial and fungal membranes (their outer skins). It pushes into them and forms pore-like holes, and the cells burst. Lactoferricin also grabs iron, so germs lack the iron they need to grow and to make the factors that make them harmful. It also tunes the body's first-line immune defense through TLR4 signaling (a germ-sensing pathway on immune cells), boosts natural killer cell activity (immune cells that destroy infected or abnormal cells), and lowers pro-inflammatory cytokines (proteins that spread inflammation). So it both kills germs directly and adjusts the immune response.

Evidence check

Some human studies

It has been tested in people, but only in small or early-stage studies. Promising, but not yet proven the way an approved medicine is.

Every numbered marker on this page links to one of the 5 sources at the bottom.

94/100

Fighting Germs

This peptide punches holes in harmful bacteria and fungi, working against many types that even some antibiotics struggle with.

86/100

Cancer Cell Targeting

It can spot and attack cancer cells while leaving healthy cells mostly alone, thanks to differences in their outer surfaces.

82/100

Immune Support

Boosts your body's natural defense team by helping immune cells work better and calming down harmful inflammation.

What the research points to

  • Kills a wide range of germs: Gram-positive bacteria (bacteria with a thick cell wall; S. aureus MIC 2-64 µg/mL), Gram-negative bacteria (bacteria with a thin, double-layered wall; E. coli MIC 0.3-150 µg/mL), and fungi (Candida species). It works by quickly punching holes in their outer membrane and by hitting targets inside the cell. (MIC is the lowest dose that stops growth.)
  • Breaks up biofilms (slimy germ colonies that stick to surfaces) of S. aureus and P. aeruginosa. At doses too low to kill germs, it still stops biofilms from forming, and it helps regular antibiotics get into biofilms that already exist
  • Attacks certain cancer cells in lab tests: breast cancer (MCF-7 IC50 22 µM for the four-chain form; IC50 is the dose that kills half the cells), leukemia, fibrosarcoma (a cancer of connective tissue), and neuroblastoma (a cancer of nerve cells). It favors cancer cell membranes because they carry a negative charge
  • Your body already makes it during digestion: pepsin (a stomach enzyme) cuts the lactoferrin (a milk protein) in cow's milk, which releases lactoferricin B and gives the gut a built-in germ defense
  • Contains the RRWQWR hexapeptide motif (a six-amino-acid stretch) that its germ-killing and anticancer effects depend on. This smallest active piece lets researchers design shorter, stronger synthetic versions
  • Also tunes the immune system, beyond killing germs directly: it boosts natural killer cell activity (immune cells that destroy infected or abnormal cells), helps macrophages (immune cells that swallow germs) do their job, and adjusts inflammation signals (lowers TNF-α and IL-6 in macrophages stimulated with LPS, a bacterial toxin)

The most-asked question

How much Lactoferricin B do I take?

The research-reported range is 1–10 mg, multiple times daily.

Adjusting your dose

You're at the right dose if…

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Consider going up if…

  • You've tolerated the current dose for the recommended period without significant side effects
  • Therapeutic goals haven't been met at the current dose level
  • Your healthcare provider recommends dose escalation based on your response
  • Lab work or clinical assessments support a higher dose

Go down if…

  • Side effects are bothersome or impacting daily life despite management strategies
  • You experience any signs of an adverse reaction
  • Lab results indicate the need for dose reduction
  • Your healthcare provider recommends a lower dose based on your response

The ceiling: 10 (as determined by your healthcare provider based on individual response and tolerance)

Reconstitution, in plain words

How do I mix Lactoferricin B?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Lactoferricin B:

What you need

  • Lactoferricin B in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

A worked example

Lactoferricin B comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Working out your dose

Use Lactoferricin B exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Lactoferricin B's recorded schedule.

Lactoferricin BThree quick questions

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Timing

When do I take Lactoferricin B?

Best time of day

Take Lactoferricin B at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With or without food?

Lactoferricin B can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

Taking it with other peptides

Lactoferricin B should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

The honest list

What side effects could Lactoferricin B cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

  • Mild stomach and gut discomfort

    Bloating, mild nausea, or slight abdominal discomfort with oral research doses. Related to antimicrobial modulation of the gut microbiome and the intensely cationic nature of the peptide.

    What to do Take with food. Start with lower doses and titrate (stepping the dose up gradually) up. Usually resolves within 2-3 days as the GI tract adjusts.

  • Bitter taste

    Characteristic bitter taste of cationic peptides with high arginine content when taken orally without capsule encapsulation.

    What to do Use enteric-coated capsules or mix with flavored vehicle. Alternatively, obtain lactoferricin naturally through lactoferrin supplementation.

  • Local irritation (topical use)

    Mild redness, warmth, or stinging at the topical application site related to the peptide's interaction with skin tissue.

    What to do Use appropriate buffer and formulation vehicle. Reduce concentration if irritation persists. Self-limiting.

  • Mild gas (flatulence)

    Increased gas production from antimicrobial effects on gut microbiota, particularly in the first few days of oral administration.

    What to do Transient — resolves as gut microbiome adjusts. Take with meals. Consider probiotic co-administration.

Less common

Worth knowing about, but most people never see these.

  • Allergic reaction in milk-sensitive individuals

    Urticaria, GI upset, or mild allergic symptoms in individuals with bovine milk protein sensitivity. Lactoferricin is derived from bovine lactoferrin.

    What to do Discontinue immediately if allergic reaction occurs. Antihistamines for mild reactions. Individuals with known cow milk protein allergy should avoid bovine lactoferricin.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

  • Damage to red blood cells (hemolytic activity) at high concentrations

    Lactoferricin B demonstrates hemolytic activity at concentrations above approximately 100 µg/mL, limiting the therapeutic window particularly for potential systemic (affecting the whole body) applications.

    What to do Maintain dosing within established therapeutic range (<100 µg/mL). Monitor for signs of hemolysis in research protocols. The therapeutic window between antimicrobial (MIC 0.3-64 µg/mL) and hemolytic activity provides adequate margin for most applications.

Week by week

What should I expect from Lactoferricin B, and when?

  1. Hours 0-24 (initial exposure)

    You might notice
    • Direct antimicrobial killing begins within minutes of contact with bacteria
    • Mild GI discomfort possible with oral administration
    • Topical application: mild local redness at contact site
    • No immediate systemic (affecting the whole body) effects at standard doses
    What's normal
    • Lactoferricin B achieves bactericidal activity within 30-60 minutes in vitro (in lab dishes, not living bodies)
    • GI effects are transient and reflect antimicrobial interaction with gut flora
    • The peptide is naturally produced during every digestion of lactoferrin-containing foods
    • Salt conditions influence activity — low-salt environments show strongest effects
    What's next
    • Continue daily dosing per research protocol
    • Check antimicrobial results (cultures, and biofilm tests that measure bacteria growing in sticky protective layers) at 24-48 hours
    • Watch for any allergic reactions in first-time users
    • Stomach and gut effects typically clear within 2-3 days
  2. Days 2-7 (active research phase)

    You might notice
    • Fewer disease-causing bacteria in research models
    • Effects against biofilm (the sticky protective layers bacteria form) become clearer with repeated exposure
    • Immune effects are developing: more NK cell activity (NK cells are immune cells that kill infected cells) and changes in cytokines (the immune system's chemical messengers)
    • Stomach and gut side effects typically clearing
    What's normal
    • Antimicrobial activity is maintained with consistent dosing
    • Biofilm disruption requires sustained exposure over multiple days
    • Immune cell modulation effects build over days of exposure
    • Salt-sensitivity remains — maintain appropriate formulation conditions
    What's next
    • Continue through planned protocol duration
    • Collect intermediate timepoint data for research endpoints
    • Assess for any emerging tolerability concerns
    • Consider combination protocols if synergy with antibiotics is being evaluated
  3. Week 2-4 (extended protocols)

    You might notice
    • Full antimicrobial and immunomodulatory effects established
    • Anti-biofilm efficacy at maximum in extended treatment models
    • Anticancer endpoints assessable in relevant in vivo (in living animals or people) models
    • Good tolerability typically maintained with oral and topical routes
    What's normal
    • No resistance development expected — membrane disruption mechanism resists adaptation
    • Sustained immunomodulatory effects with continued exposure
    • Anticancer activity in preclinical (animal or lab studies, not human trials) models typically assessed at 2-4 week endpoints
    • Research outcomes ready for analysis
    What's next
    • Compile research data and assess endpoints
    • Consider protocol modifications for future studies
    • Evaluate potential for synthetic analog (a modified version of a natural molecule) development based on RRWQWR motif
    • Plan follow-up studies addressing salt-sensitivity limitations for clinical translation

How to tell it's actually working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Lactoferricin B over time
  • Reduction in symptom frequency or severity

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing anything? The usual reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

Is it right for you?

Who should avoid Lactoferricin B?

Do not use it if…

  • Known allergy to bovine milk proteins or lactoferrin — cross-reactivity possible
  • Pregnancy and breastfeeding — insufficient safety data for therapeutic-dose lactoferricin supplementation
  • Active hemolytic conditions — at higher concentrations lactoferricin shows some hemolytic activity that may worsen hemolysis
  • Iron overload conditions (hemochromatosis) — lactoferricin retains some iron-binding capacity from the parent lactoferrin molecule

Be extra careful if…

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Lactoferricin B use
  • You have any chronic health conditions that require regular monitoring

When to stop

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Lactoferricin B
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Lactoferricin B should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

What it mixes badly (and well) with

Medications

  • Avoid
    High-concentration NaCl solutions (>150 mM) — salt sensitivity reduces lactoferricin's electrostatic membrane binding and antimicrobial potency significantly

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Iron supplements at the same time — iron may compete for residual binding sites on the lactoferricin fragment and alter peptide activity

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Anionic polysaccharides in excess (carrageenan, xanthan gum) — may electrostatically sequester the cationic lactoferricin peptide

    Use with caution—discuss with your healthcare provider.

Other peptides

  • OK together
    Bovine lactoferrin (parent protein — oral lactoferrin generates lactoferricin during digestion; co-administration provides both intact lactoferrin immune benefits and lactoferricin antimicrobial activity)

    May be used together under medical guidance.

  • OK together
    Probiotics (Lactobacillus, Bifidobacterium species — lactoferricin selectively inhibits pathogens while sparing beneficial bacteria, supporting targeted microbiome modulation)

    May be used together under medical guidance.

  • OK together
    Conventional antibiotics (demonstrated synergy — lactoferricin permeabilizes bacterial membranes, enhancing intracellular antibiotic accumulation in resistant organisms)

    May be used together under medical guidance.

Supplements

  • OK together
    Multivitamins

    Generally safe to take alongside Lactoferricin B. Space doses apart if taking oral formulations to ensure optimal absorption.

  • OK together
    Electrolyte supplements

    Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Who it tends to suit

Research into germ-killing peptides from dairy and the body's built-in first-line defenses

Lactoferricin B is particularly well-suited for individuals focused on research into dairy-derived antimicrobial peptides and natural innate defense mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Studying how the shape of germ-killing peptides (beta-sheet peptides, flat folded ones) affects how well they work

Lactoferricin B is particularly well-suited for individuals focused on investigation of structure-activity relationships in beta-sheet antimicrobial peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Early lab development of anticancer peptides that target the uneven fat layout of cancer cell membranes (membrane phospholipid asymmetry)

Lactoferricin B is particularly well-suited for individuals focused on preclinical (animal or lab studies, not human trials) development of anticancer peptides targeting membrane phospholipid asymmetry. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Understanding the germ defense in the gut that comes from digesting lactoferrin (a milk protein) in food

Lactoferricin B is particularly well-suited for individuals focused on understanding the gastrointestinal antimicrobial defense provided by dietary lactoferrin digestion. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

The safety picture overall

Lactoferricin B is a 25-amino acid peptide fragment of bovine lactoferrin, a protein found in cow's milk 2. Preclinical (animal or lab studies, not human trials) studies show excellent tolerability with no hepatotoxicity, nephrotoxicity, or genotoxicity in animal models even at supraphysiological doses. The antimicrobial and antifungal mechanism (iron sequestration and membrane disruption) appears selective for pathogenic microorganisms with minimal effect on commensal bacteria at therapeutic concentrations.

Lactoferricin B safety is supported by extensive in vitro (in lab dishes, not living bodies) germ-killing data 12 and preclinical (animal or lab studies, not human trials) pharmacology studies published in Peptides and Antimicrobial Agents and Chemotherapy. Human clinical data remain limited to small feasibility studies and studies of how well it is absorbed by mouth. Oral absorption is low because enzymes that cut proteins (peptidases) break it down, which limits how much reaches the body. Topical and intranasal use show local benefit in pilot studies without documented body-wide adverse events.

Keeping it good

How do I store Lactoferricin B?

Before mixing (powder)

Store Lactoferricin B in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After mixing (liquid)

Once reconstituted, Lactoferricin B should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs it has gone bad

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Not our opinion — the published record

What the studies actually found about Lactoferricin B

If this isn't the right fit

What people use instead of Lactoferricin B

Alternative approaches for immune support

  • Consult your healthcare provider for alternatives to Lactoferricin B based on your specific needs and medical history

Other immune-support peptides

  • Thymosin Alpha-1
  • LL-37
  • Thymulin

Non-peptide immune support

  • Vitamin D3
  • Zinc supplementation
  • Beta-glucans

Your questions

Lactoferricin B FAQ

Is lactoferricin the same as lactoferrin?

No. Lactoferrin is a large 80 kDa iron-binding glycoprotein found in milk, tears, saliva, and other body fluids. Lactoferricin B is a small 25-amino-acid peptide fragment that is released when bovine lactoferrin is cleaved by the digestive enzyme pepsin in the stomach. Importantly, lactoferricin B is 10-100 times more potent as an antimicrobial than intact lactoferrin. When you take a lactoferrin supplement, your stomach acid and pepsin naturally generate lactoferricin during digestion.

Why is it called lactoferricin 'B' — is there an 'H' version?

Yes. The 'B' stands for bovine (cow). Lactoferricin H is the human equivalent, derived from human lactoferrin residues 1-47. However, lactoferricin H has a significantly different amino acid sequence and generally weaker antimicrobial activity compared to the bovine form. Most research has focused on lactoferricin B because of its greater potency and the abundance of bovine lactoferrin as a starting material.

What makes the RRWQWR motif (a six-amino-acid stretch) so important?

The hexapeptide RRWQWR (Arg-Arg-Trp-Gln-Trp-Arg) within lactoferricin B has been identified through systematic truncation and mutagenesis studies as the minimal sequence required for antimicrobial and anticancer activities. The two arginine residues provide positive charge for electrostatic membrane binding, while the two tryptophan residues provide the hydrophobic anchoring needed for membrane insertion. This motif has been used as a template for designing shorter, more potent synthetic antimicrobial peptides.

Why is salt sensitivity a problem for lactoferricin?

Lactoferricin B's antimicrobial activity is substantially reduced at physiological salt concentrations (150 mM NaCl) because sodium and chloride ions screen the electrostatic interactions between the cationic peptide and anionic bacterial membranes. This means in vitro (in lab dishes, not living bodies) activity at low-salt conditions may not fully translate to activity in blood, wound fluid, or other body fluids with physiological salt levels. This is the major barrier to clinical development and the focus of synthetic analog (a modified version of a natural molecule) design efforts.

Does eating dairy products give you lactoferricin?

Yes, to some extent. Bovine lactoferrin is present in cow's milk, especially colostrum and whey. During normal digestion, stomach acid and pepsin cleave lactoferrin to release lactoferricin B. However, the amount generated from normal dietary intake is relatively small compared to research doses. Lactoferrin supplements (typically 100-500 mg) provide a more concentrated source. Interestingly, infant formula supplemented with bovine lactoferrin has been studied for its protective effects against neonatal infections.

Can lactoferricin help with cancer?

Preclinical (animal or lab studies, not human trials) research shows promising selective anticancer activity. Lactoferricin B, particularly in tetrameric (four-copy linked) form, shows cytotoxicity against breast cancer (MCF-7 IC50 22 µM), leukemia, fibrosarcoma, and neuroblastoma cells. The selectivity comes from cancer cells exposing anionic phosphatidylserine on their outer membrane, which normal cells keep hidden on the inner leaflet. However, all evidence is preclinical — no human clinical trials for cancer have been conducted with lactoferricin.

5 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the Lactoferricin B research profile on Peptide Initiative.

  1. Killing of Gram-negative and Gram-positive bacteria by lactoferricin, a peptide derived from bovine lactoferrinBellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M · 1992
  2. Antimicrobial properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrinBellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M · 1992
  3. Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived PeptidesGruden Š, Poklar Ulrih N · 2021
  4. Bovine lactoferricin exerts antibacterial activity against four Gram-negative pathogenic bacteria by transforming its molecular structurePei J, Xiong L, Wu X, et al. · 2025
  5. The tetrameric peptide LfcinB (20-25)(4) derived from bovine lactoferricin induces apoptosis in the MCF-7 breast cancer cell lineGuerra JR, Cárdenas AB, Ochoa-Zarzosa A, et al. · 2019

Want the deep science?

Read the full Lactoferricin B research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More immune system guides

This guide is education, not medical advice. Lactoferricin B is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.